Symbol | Exchange | Currency |
|---|
Investing.com – U.S. stocks were mixed after the close on Tuesday, as gains in the Oil & Gas, Financials and Basic Materials sectors led shares higher while losses in the...
By Sam BougheddaInvesting.com — Shares of Avrobio Inc (NASDAQ:AVRO) are down 33% Tuesday after the company announced that it is shifting its portfolio priorities — deprioritizing...
H.C. Wainwright analyst Debjit Chattopadhyay reiterated a Hold rating on Avrobio (NASDAQ:AVRO) Inc on Monday, setting a price target of $13, which is approximately 9.53% below the...
AVROBIO, Inc. (NASDAQ:AVRO) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front....
AVROBIO, Inc. (NASDAQ:AVRO) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors...
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company’s product includes AVR-RD-01, a gene therapy for the treatment of Fabry disease. It is also developing AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of type 1 Gaucher disease; AVR-RD-03, for the treatment of Pompe disease; AVR-RD-04 for the treatment of cystinosis; AVR-RD-05 for the treatment of Hunter syndrome; and AVR-RD-06 that is in preclinical stage for the treatment of Gaucher disease type 3. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Buy | Sell |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 96.92 | 98.76 | 96.16 | +1.38 | +1.44% | 11.03M | NASDAQ | |||
| 49.88 | 50.00 | 49.71 | +0.10 | +0.21% | 1.03M | NYSE | |||
| 89.94 | 91.30 | 88.56 | -1.25 | -1.37% | 3.75M | NYSE | |||
| 239.74 | 239.78 | 236.60 | +9.80 | +4.26% | 918.28K | NASDAQ | |||
| 0.0001 | 0.0002 | 0.0001 | 0.00000 | 0.00% | 0.00 | OTC Markets | |||
| 7.64 | 8.08 | 7.50 | +0.72 | +10.40% | 1.51M | NYSE | |||
| 105.57 | 106.36 | 104.06 | +4.14 | +4.08% | 564.27K | NASDAQ | |||
| 172.94 | 176.68 | 169.82 | +1.80 | +1.05% | 478.86K | NASDAQ | |||
| 429.69 | 430.55 | 426.44 | +1.14 | +0.27% | 74.71K | NYSE | |||
| 4.02 | 4.75 | 4.02 | +0.340 | +9.24% | 7.56M | NASDAQ | |||
| 0.005 | 0.0144 | 0.005 | 0.0000 | 0.00% | 0.00 | OTC Markets | |||
| 15.40 | 15.57 | 15.33 | +0.36 | +2.39% | 15.89M | NYSE | |||
| 38.81 | 39.85 | 38.36 | +2.06 | +5.61% | 5.28M | NYSE | |||
| 19.35 | 19.89 | 19.01 | +0.11 | +0.57% | 33.80K | NASDAQ | |||
| 170.77 | 171.24 | 170.70 | +0.59 | +0.35% | 279.11K | NYSE |